Insmed Incorporated
USD104.74
+1.36 (+1.32%)
CEO
William H. Lewis
IPO Date
2000-06-01
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$105.36
Prev. Close
$103.38
Day Low
$103.96
Day High
$106.39
52W Low
$90.39
52W High
$212.75
Market Cap
$22.70B
Volume
2.68M
| -12.4 |
| 31 Dec 2023 | FY | 78.5% | -245.6% | 225.8% | -56.4% | -3.63 | 4.12 | -5.8 |
| 31 Dec 2022 | FY | 77.5% | -196.3% | -547.5% | -29.1% | 13.39 | 6.69 | -5.1 |
| 31 Dec 2021 | FY | 76.6% | -230.6% | -105.9% | -35.0% | 1.49 | 6.19 | -7.0 |
| 31 Dec 2020 | FY | 75.7% | -178.9% | -106.6% | -36.9% | 1.47 | 5.24 | -11.0 |
| 31 Dec 2019 | FY | 82.3% | -186.4% | -97.2% | -34.3% | 1.52 | 6.51 | -7.9 |
| 31 Dec 2018 | FY | 75.4% | -3297.2% | -155.7% | -53.6% | 1.52 | 6.51 | -3.1 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -53.4% | -41.7% | 0.15 | 8.72 | -10.8 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -114.1% | -74.1% | 0.35 | 6.02 | -4.6 |
| -28.3 |
| 30 Sept 2025 | Q3 | 79.4% | -260.0% | -39.1% | -15.7% | 0.79 | 4.63 | -20.6 |
| 30 Jun 2025 | Q2 | 73.9% | -299.5% | -25.7% | -13.0% | 0.59 | 6.68 | -14.8 |
| 31 Mar 2025 | Q1 | 77.1% | -276.4% | -258.8% | -14.2% | 13.21 | 5.86 | -13.4 |
| 31 Dec 2024 | Q4 | 75.0% | -225.5% | -82.5% | -11.6% | 4.60 | 5.45 | -13.1 |
| 30 Sept 2024 | Q3 | 77.3% | -236.0% | -45.6% | -10.7% | 2.41 | 6.37 | -14.4 |
| 30 Jun 2024 | Q2 | 76.8% | -332.8% | -774.4% | -16.6% | 35.53 | 2.71 | -8.5 |
| 31 Mar 2024 | Q1 | 76.9% | -208.1% | 33.8% | -13.6% | -2.95 | 1.80 | -6.3 |
| 31 Dec 2023 | Q4 | 78.0% | -222.3% | 56.1% | -14.0% | -4.10 | 4.12 | -6.0 |